Key Decision and Effective Date
Based on the recommendation of the Nomination and Remuneration Committee, the Board of Directors of Alkem Laboratories Limited, at its meeting held on 03rd November 2026, appointed Dr. Amrut Naik as the Chief Executive Officer (CEO) and Key Managerial Personnel of the Company. The appointment is effective from 11th November 2026.
Term of Appointment
The term of appointment is for the duration of his employment with the Company ("Duration of the contract shall be so long as he is in employment of the Company").
Executive Profile Details
Dr. Amrut Naik is a seasoned global pharmaceutical business leader with over 26 years of hands-on experience in building, scaling, and transforming global businesses across Branded Formulations, Generics, APIs, Biologics, Vaccines, Specialty, and Innovation-led portfolios. His educational qualifications include a Ph.D. (Tech) in Pharmacology, a Master's in Pharmaceutical Science, and a Bachelor's in Pharmaceutical Science.